IL299287A - Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis - Google Patents
Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosisInfo
- Publication number
- IL299287A IL299287A IL299287A IL29928722A IL299287A IL 299287 A IL299287 A IL 299287A IL 299287 A IL299287 A IL 299287A IL 29928722 A IL29928722 A IL 29928722A IL 299287 A IL299287 A IL 299287A
- Authority
- IL
- Israel
- Prior art keywords
- kits
- methods
- dosing regimen
- dose combination
- combination products
- Prior art date
Links
- 206010062207 Mycobacterial infection Diseases 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 229940000425 combination drug Drugs 0.000 title 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 title 1
- 230000002685 pulmonary effect Effects 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046322P | 2020-06-30 | 2020-06-30 | |
| US202063046335P | 2020-06-30 | 2020-06-30 | |
| PCT/IB2021/000451 WO2022003421A2 (en) | 2020-06-30 | 2021-06-30 | Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299287A true IL299287A (en) | 2023-02-01 |
Family
ID=79032054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299287A IL299287A (en) | 2020-06-30 | 2021-06-30 | Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11590154B2 (https=) |
| EP (1) | EP4171546A4 (https=) |
| JP (1) | JP2023533472A (https=) |
| KR (1) | KR20230028502A (https=) |
| CN (1) | CN115768420A (https=) |
| AU (1) | AU2021298936A1 (https=) |
| BR (1) | BR112022026615A2 (https=) |
| CA (1) | CA3187031A1 (https=) |
| IL (1) | IL299287A (https=) |
| MX (1) | MX2023000165A (https=) |
| WO (1) | WO2022003421A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025026423A1 (en) * | 2023-08-02 | 2025-02-06 | Shenzhen Pharmacin Co., Ltd. | Compositions, their use and manufacture for treatment of gastrointestinal conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0971735B1 (en) | 1997-04-01 | 2008-03-19 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
| PT2247291T (pt) | 2008-02-08 | 2019-02-01 | Red Hill Biopharma Ltd | Métodos e composições para tratamento de doença inflamatória do intestino |
| TWI573590B (zh) * | 2011-09-20 | 2017-03-11 | 雷希爾生藥有限公司 | 治療自體免疫疾病之組成物及方法 |
| US20180273573A1 (en) | 2015-10-01 | 2018-09-27 | Memorial Sloan-Kettering Cancer Center | Inhibitors of menaquinone biosynthesis |
| WO2017194734A1 (en) | 2016-05-13 | 2017-11-16 | Technische Universität München | Means and methods for treating mycobacterial diseases |
-
2021
- 2021-06-30 WO PCT/IB2021/000451 patent/WO2022003421A2/en not_active Ceased
- 2021-06-30 AU AU2021298936A patent/AU2021298936A1/en active Pending
- 2021-06-30 MX MX2023000165A patent/MX2023000165A/es unknown
- 2021-06-30 CN CN202180044988.XA patent/CN115768420A/zh active Pending
- 2021-06-30 CA CA3187031A patent/CA3187031A1/en active Pending
- 2021-06-30 BR BR112022026615A patent/BR112022026615A2/pt unknown
- 2021-06-30 IL IL299287A patent/IL299287A/en unknown
- 2021-06-30 EP EP21834321.8A patent/EP4171546A4/en not_active Withdrawn
- 2021-06-30 KR KR1020237002839A patent/KR20230028502A/ko active Pending
- 2021-06-30 US US17/364,124 patent/US11590154B2/en active Active
- 2021-06-30 JP JP2022580214A patent/JP2023533472A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022003421A3 (en) | 2022-03-17 |
| US11590154B2 (en) | 2023-02-28 |
| BR112022026615A2 (pt) | 2023-01-24 |
| JP2023533472A (ja) | 2023-08-03 |
| CA3187031A1 (en) | 2022-01-06 |
| US20210401865A1 (en) | 2021-12-30 |
| KR20230028502A (ko) | 2023-02-28 |
| AU2021298936A1 (en) | 2023-01-19 |
| CN115768420A (zh) | 2023-03-07 |
| EP4171546A2 (en) | 2023-05-03 |
| WO2022003421A2 (en) | 2022-01-06 |
| EP4171546A4 (en) | 2024-03-13 |
| MX2023000165A (es) | 2023-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3805264A4 (en) | ANTI-INTERLEUKIN 17A ANTIBODIES, PHARMACEUTICAL COMPOSITION AND USE | |
| IL275798A (en) | Methods for antibody drug conjugation, purification and formulation | |
| ZA202106928B (en) | Packet for cigarette industry products, and method for producing same | |
| EP4063483A4 (en) | MODIFIED CYANOBACTERIA, METHOD FOR PRODUCING MODIFIED CYANOBACTERIA AND METHOD FOR PRODUCING PROTEINS | |
| EP3992194A4 (en) | BENZODIAZEPIN COMPOUND, METHOD OF MANUFACTURE AND USE THEREOF IN MEDICINE | |
| IL317671A (en) | History of anilinopyrazole, its preparations and methods | |
| EP4095232A4 (en) | BACTERIA, COMPOSITION AND PRODUCTION METHOD THEREFOR, AND COMPOSITION OF PREBIOTICS | |
| IL299287A (en) | Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis | |
| EP3942965A4 (en) | RUBBER COMPONENT, COMB AND METHOD OF MANUFACTURING THEREOF | |
| IL288953A (en) | Pharmaceutical compounds, kits and methods for the treatment of cancerous tumors | |
| EP4219504A4 (en) | MACROCYCLIC TLR7 AGONIST, MANUFACTURING METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP4059985A4 (en) | Polyether-modified siloxane, paint additive, paint composition, coating agent, coating layer, and method for producing polyether-modified siloxane | |
| EP3846825A4 (en) | FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND RELATED SYSTEMS, METHODS AND ARTICLES | |
| EP4130381A4 (en) | METHOD FOR PRODUCING A ROAD BASE COURSE AND MIXTURE FOR USE IN THIS METHOD | |
| EP4108236A4 (en) | PHARMACEUTICAL OLAPARIB COMPOSITION, MANUFACTURE THEREOF, MANUFACTURING METHOD THEREOF AND USE THEREOF | |
| EP4477733A4 (en) | COMPOSITION, MANUFACTURING METHOD AND USE | |
| PL4164998T3 (pl) | WŁÓKNA MULITOWE WZMOCNIONE ZrO2, SPOSÓB ICH WYTWARZANIA I ICH ZASTOSOWANIE | |
| SG11202109359RA (en) | Composition comprising block copolymer, and method for producing siliceous film using the same | |
| EP3974445A4 (en) | BISPECIFIC MOLECULE, ITS MANUFACTURE AND USE | |
| EP4248964A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEPSIS AND USE THEREOF | |
| EP3988593A4 (en) | BLOCK COPOLYMER INTERMEDIATE, BLOCK COPOLYMER AND METHODS OF PRODUCING THEM | |
| EP4050079A4 (en) | COMPOSITION OF LIQUID REPELLENT AGENT, METHOD FOR PRODUCING SAME AND CORRESPONDING ARTICLE | |
| EP4039857A4 (en) | AGENT PROVIDING A FRESH-ON-CONTACT FEELING AND WATER-ABSORBING/QUICK-DRYING PROPERTIES, AND METHOD FOR PROVIDING A COOL-ON-CONTACT FEELING AND WATER-ABSORBING/QUICK-DRYING PROPERTIES TO AN ARTICLE | |
| EP4067307A4 (en) | HIGHLY WEAR-RESISTANT ZEOLITE MOLDED ARTICLE AND METHOD FOR MANUFACTURING THE SAME | |
| EP4039717A4 (en) | COMPOSITION OF WATER-REPELLENT AND OIL-REPELLENT AGENT, METHOD FOR PRODUCTION THEREOF AND ARTICLE |